Abstract This report discusses a new development in the use of ultrasound microbubble contrast agents on transdermal drug delivery. The medium surrounding the microbubbles at the optimum concentration from liquid to gel can be modified and it can still achieve the same enhancement for transdermal drug permeation as liquid medium. It was also found that under the same ultrasound power density, microbubbles of larger particle sizes can extend the penetration depths of dye at the phantom surface. ª
In current practice, there are three types of transdermal drug absorption: (1) direct permeation through the lipideprotein matrix of the stratum corneum; (2) permeation through intercellular lamellar lipid bilayers; and (3) permeation across the skin barrier in the subsidiary organs (hair follicles and sweat glands) to reach subcutaneous tissue [1, 2] . Because the stratum corneum is hydrophobic, large molecules or hydrophilic drugs are likely to be transported through subsidiary organs; however, hair follicles, sweat glands, and sebaceous glands constitute only 0.1% of the total skin area. Therefore, the main route of drug transport is permeation across the stratum corneum. Published reports have claimed that damage to the stratum corneum can increase the amount of drug that is absorbed, suggesting that the stratum corneum is the main factor that influences drug permeation. The stratum corneum can hinder the rate of skin permeation of drugs, allowing only small molecules (with a molecular weight < 500 Da) to permeate through [3] . At present, there are numerous methods to improve transdermal drug transport, including physical permeation-enhancement technology (iontophoresis, electrophoresis, ultrasound, microneedles, and laser), chemical permeation-enhancement technology [various chemical permeation enhancers including copper(II) azide], and pharmaceutical approaches (microemulsions, liposomes, and nanoparticles). Moreover, drugs can be applied to the skin in the form of creams, ointments, and patches. In recent years, microneedle array has been considered a novel minimally invasive approach to enhance transdermal permeation of large molecule drugs. This report discusses a new development in the use of ultrasound microbubble contrast agents on transdermal drug delivery.
In clinical applications, microbubbles serve as imaging agents to enhance the contrast of ultrasound images via intravenous injection. Different degrees of microbubble oscillation due to distinct acoustic fields can elicit various degrees of cavitation. Inertial cavitation can enhance the permeability in the surrounding tissues, increase vessel wall permeability, and promote drug entry from blood into the cytosol or matrix, whereas stable cavitation can slightly increase tissue permeability without causing any harm. In November 2015, Canadian researchers, for the first time, utilized focused ultrasound to cause preinjected microbubble contrast agents in the blood vessels to vibrate, successfully opening the bloodebrain barrier in the human brain, thus allowing more effective delivery of chemotherapy into a brain tumor [4] . This approach is based on cavitation generated by ultrasound-driven microbubble oscillation. In 2010, scientists in Korea first conducted an in-vitro experimental study to investigate the potential of microbubbles for transdermal drug permeation, and found that the combination of ultrasound and microbubbles can indeed effectively promote transdermal permeation. During their research, they discovered that by evenly applying 0.1% commercial ultrasound microbubble contrast agent in conjunction with designated ultrasound energy, cavitation can be generated more uniformly in the skin area of interest and thus increase skin permeability [5] .
At present, most ultrasound contrast agents are designed for injection into blood vessels; nevertheless, microbubbles with different condition parameters are highly correlated with efficiency in transdermal permeation. In a study published by our laboratory in 2013, we found that on the round window membrane of the ear, the efficiency of drug delivery can be greatly improved by up to 38 times, with the use of microbubbles at a specific concentration coupled with ultrasound to increase permeability of the round window membrane, followed by application of the drug onto the round window membrane [6] . As for applications in a transdermal permeation, we also used microbubbles at a given concentration in combination with ultrasound to widen intercellular spaces (Figure 1) , thereby successfully enhancing the in vivo delivery of arbutin across the skin. In order for liquidphase microbubbles to be conveniently applied to the skin surface, our team modified the medium surrounding the microbubbles at the optimum concentration from liquid to gel. Although gel medium slightly hinders the efficiency of microbubble oscillation, it can still achieve the same enhancement for transdermal drug permeation as liquid medium does with the adjustments toward optimum gel ratio and microbubble concentration [7] ; Figure 1 Schematic diagram of ultrasound-mediated microbubble contrast agents for enhancement of transdermal permeation. US Z ultrasound. Figure 2 The upper row represents the variation in depth of penetration of the dye in phantoms after loading microbubbles of different particle sizes in combination with sonication at the same power density; the lower row shows the corresponding images acquired after edge detection. U Z ultrasound.
however, questions about the regulation of drug penetration depth and the permeation of big molecule drugs still merit attention.
Subsequently, our research team controlled the microbubble diameter at three distinct particle sizes of 1.4 mm, 2.1 mm, and 3.5 mm by changing the formulation ratios during the microbubble production process, and conducted agarose phantom experiment coupled with ultrasound at different power densities. Figure 2 shows different penetration depths of the dye in tissue phantoms after loading microbubbles of different sizes followed by a successive sonication at the power density of 3 W/cm 2 for 1 minute. It was found that under the same ultrasound power density, microbubbles of larger particle sizes can extend the penetration depths of dye at the phantom surface. Additionally, our drug transport model and in vivo results have demonstrated that the combination of lipophilic vitamin C derivative (with the molecular weight of 1129.8 Da) and 3.5-mm microbubbles along with ultrasound is the most effective in enhancing transdermal permeation [8] . Thus, we conclude that microbubbles play a versatile and significant role in the process of ultrasound-driven drug delivery, with the versatility to adjust variations in drug permeation as their greatest advantage over other drugenhancement approaches.
